| Sign In to gain access to subscriptions and/or personal tools. |
Effect of candesartan cilexetil on carotid intima-media thickness in hypertensive type 2 diabetic patients. MITEC study: design and baseline characteristicsService d'Endocrinologie-Diabétologie-Nutrition, Hôpital Jean Verdier, APHP/CRNH-IdF, Bondy, France, paul.valensi{at}jvr.aphp.fr
Service de Cardiologie et Hypertension Artérielle, CHU de Grenoble, France
Institut CardioVasculaire, Paris, France
Laboratoires TAKEDA France, Puteaux, France
Service de Cardiologie et Hypertension Artérielle, CHU de Grenoble, France Media Intima Thickness Evaluation of Candesartan (MITEC), a multicentre, randomised, double-blind, parallel-group study assessed the effect of candesartan cilexetil (CC) versus amlodipine (AML) administered during three years, on carotid intima-media thickness (IMT) in hypertensive type 2 diabetic patients. The study design, the baseline characteristics, and the determinants of carotid IMT are presented. After a placebo run-in period of four weeks, patients were randomised to CC (n=100) or AML (n=109). The mean blood pressure values were 155.9±11.0 mmHg, 91.3± 8.0 mmHg and 64.6±11.8 mmHg for systolic, diastolic and pulse pressure respectively, and the mean HbA1C was 7.1±1.3%. The mean common carotid IMT was 0.74±0.16 mm. The univariate regression analyses showed a significant correlation between IMT and age (p<0.0001), gender (p=0.013) and creatinine clearance (p=0.03). Only age was significantly correlated with carotid IMT (p<0.0001) in the multivariate analysis. In conclusion, the MITEC population has good metabolic control at baseline where carotid IMT is mainly related with age.
Key Words: candesartan cilexetil amlodipine carotid intima-media thickness diabetes hypertension.
The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 1,
18-24 (2007) |
|||